Conference Speakers
-
Melanie Senior Commentator on the biopharma industryMelanie SeniorMelanie Senior
Biopharma writer for Nature Biotechnology, Evaluate Pharma, IN VIVO
Bio
Melanie Senior is a renowned commentator on the biopharma industry, recognised internationally for her insights. She covers biopharma R&D, strategy and investment for the Nature portfolio, Evaluate Pharma and Citeline. Melanie also supports life sciences companies and associations with white papers and market positioning.
After starting her reporting career at the London Financial Times, Melanie became Bureau Chief, Europe, for Elsevier Business Intelligence (subsequently Informa). She worked on US reimbursement and pricing with Real Endpoints and was part of EY Life Sciences’ thought leadership team (2014-2017).
Melanie’s holds a First Class degree in Natural Sciences (biochemistry) from Cambridge University and post-graduate qualifications in Sports Physiology & Nutrition (St Mary’s University) and International Health Technology Assessment (University of Sheffield). She is a keen runner, cyclist and swimmer. -
Marianne Späne Siegfried Holding AGMarianne SpäneMarianne Späne
CBO EVP Member of the Executive Committee at Siegfried
Bio
In leading positions of the industry for more than 20 years, with a global network in the pharmaceutical and chemical environment as well as a profound understanding and extensive knowledge of the chemical and pharmaceutical market along the whole value chain.
Joined the Siegfried Group in 2004 responsible for the Pharmaceutical Business Unit between 2004 and 2008. Headed the Siegfried Pharmaceutical Division form 2008 and 2010 and appointed as Chief Business Officer as well as Member of the Global Strategy and Executive Committee in March 2010, led the execution of the transactions and implementation of Irvine sterile company (today 150 FTEs) in California.
She has a degree in finance, business administration, Marketing, Statistics, Business Analytics and Leadership., Member of the EFCG (European Chemicals Group) 2013 – 2019, Advisory Committee Member DCAT (Drug, Chemical & Associated Technologies Association, Inc.) 2014 – 2016, Elected in 2019 as one of the Top 10 influence leader in the CDMO industry
In November 2023 graduated from International Board Certificate Program, IMP of the University of St. Gallen and HEC Lausanne, about International governance. -
David Veitch Basilea PharmaceuticaDavid VeitchDavid Veitch
CEO at Basilea Pharmaceutica
Bio
David Veitch joined Basilea in 2014 as Chief Commercial Officer. Before that, from 2012 to 2013, he served as the president of European operations at Savient Pharmaceuticals. From 2007 to 2011, he served as senior vice president of European marketing & brand commercialization at Bristol-Myers Squibb Pharmaceuticals. From 2004 to 2007, he was vice president & general manager UK at Bristol-Myers Squibb Pharmaceuticals. Prior to this Mr. Veitch held various general management and commercial roles in Bristol-Myers Squibb Pharmaceuticals and prior to that commercial roles with SmithKline Beecham Pharmaceuticals.
David holds a B.Sc. in Biology from the University of Bristol. -
Karen Wagner Managing Partner at Ysios CapitalKaren WagnerKaren Wagner is a senior executive and entrepreneur with 25 years’ experience in the biopharmaceutical industry. Karen is Managing Partner at Ysios Capital and has a leading role in the investment team and the portfolio. Prior to joining Ysios in 2008, she was a Global Alliance Director for F. Hoffmann-La Roche in Basel, Switzerland. She joined Roche from GLYCART, a biotech company in the antibody engineering space, which was acquired by Roche in 2005. Previously she was a Consultant with McKinsey & Company’s Global Healthcare Practice. She serves on the Boards of Cytoki Pharma, Vivet Therapeutics, AELIX Therapeutics, Minoryx Therapeutics, Synendos and SparingVision and holds an observer seat at Xeltis. Formerly, she was Board Member at Xeltis, Cardoz, Kala Pharmaceuticals (NASDAQ:KALA), and Galecto (NASDQ:GLTO). She holds a master’s degree in Molecular Biology and a PhD in Cell Biology.